Market cap is higher because TLX is pulling $700m pa and is on track for a billion by years end.
Two more FIC products about to hit the market with conservatively $1.5b TAM between them.
A prostate therapy ph3 completed that has previously shown almost 4x overall survival of pluvicto next in line.
A tad more advanced hence the higher MC.
CU6 will do likewise eventually I'm almost certain.
Research/Valuation, page-407
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.72 |
Change
-0.170(2.47%) |
Mkt cap ! $2.119B | |||
| Open | High | Low | Value | Volume |
| $6.95 | $7.25 | $6.68 | $28.33M | 4.127M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6509 | $6.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.78 | 6841 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |